Tiger Pharmaceuticals: Disclosure of Shareholder Holding Situation on the Shareholder Registration Date for Share Repurchase Meeting.

Tiger Pharmaceuticals announced that the company approved a share buyback plan on May 13, 2026, which still needs to be approved by the shareholders' meeting. The company has disclosed the shareholding status of relevant shareholders on the day before the board of directors announced the share buyback resolution. Now, the names, shareholding quantities, and proportions of the top ten A-share shareholders and the top ten unrestricted A-share shareholders before the second interim shareholders' meeting in 2026 are disclosed. Among the top ten A-share shareholders, Ye Xiaoping holds 177,239,541 shares, accounting for 24.02%; among the top ten unrestricted A-share shareholders, Ye Xiaoping holds 44,309,885 shares, accounting for 7.83%.